NO139130C - Fremgangsmaate til fremstilling av 2-alkylamino-dihydropyridiner - Google Patents

Fremgangsmaate til fremstilling av 2-alkylamino-dihydropyridiner

Info

Publication number
NO139130C
NO139130C NO3196/73A NO319673A NO139130C NO 139130 C NO139130 C NO 139130C NO 3196/73 A NO3196/73 A NO 3196/73A NO 319673 A NO319673 A NO 319673A NO 139130 C NO139130 C NO 139130C
Authority
NO
Norway
Prior art keywords
dihydropyridines
alkylamino
preparing
procedure
Prior art date
Application number
NO3196/73A
Other languages
English (en)
Norwegian (no)
Other versions
NO139130B (no
Inventor
Horst Meyer
Friedrich Bossert
Wulf Vater
Kurt Stoepel
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of NO139130B publication Critical patent/NO139130B/no
Publication of NO139130C publication Critical patent/NO139130C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pulmonology (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO3196/73A 1972-08-12 1973-08-10 Fremgangsmaate til fremstilling av 2-alkylamino-dihydropyridiner NO139130C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2239815A DE2239815C2 (de) 1972-08-12 1972-08-12 2-Alkylamino-dihydropyridine, Verfahren zu ihrer Herstellung sowie diese enthaltende Arzneimittel

Publications (2)

Publication Number Publication Date
NO139130B NO139130B (no) 1978-10-02
NO139130C true NO139130C (no) 1979-01-10

Family

ID=5853453

Family Applications (1)

Application Number Title Priority Date Filing Date
NO3196/73A NO139130C (no) 1972-08-12 1973-08-10 Fremgangsmaate til fremstilling av 2-alkylamino-dihydropyridiner

Country Status (29)

Country Link
US (1) US3959292A (ko)
JP (1) JPS5626660B2 (ko)
KR (1) KR780000072B1 (ko)
AT (1) AT327194B (ko)
AU (1) AU469267B2 (ko)
BE (1) BE803474A (ko)
BG (1) BG22816A3 (ko)
CA (1) CA1016945A (ko)
CH (1) CH583196A5 (ko)
CS (1) CS178892B2 (ko)
DD (1) DD109627A5 (ko)
DE (1) DE2239815C2 (ko)
DK (1) DK136062C (ko)
ES (1) ES417807A1 (ko)
FI (1) FI55998C (ko)
FR (1) FR2195450B1 (ko)
GB (1) GB1384219A (ko)
HU (1) HU167991B (ko)
IE (1) IE37989B1 (ko)
IL (1) IL42933A (ko)
LU (1) LU68206A1 (ko)
NL (1) NL7311031A (ko)
NO (1) NO139130C (ko)
PL (1) PL89396B1 (ko)
RO (1) RO62914A (ko)
SE (1) SE386164B (ko)
SU (1) SU475772A3 (ko)
YU (1) YU36172B (ko)
ZA (1) ZA735460B (ko)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2639257A1 (de) * 1976-09-01 1978-03-02 Bayer Ag Aminoalkylidenamino-1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
US4442100A (en) * 1979-12-11 1984-04-10 Bayer Aktiengesellschaft Substituted 2-amino-3,4-dihydropyridine derivatives, their production and their medicinal use
DE3134945A1 (de) * 1981-09-03 1983-03-17 Bayer Ag, 5090 Leverkusen Substituierte 2-amino-3,4-dihydropyridinderivate, verfahren zu ihrer herstellung und ihre verwendung in arzneimittel
ATE50987T1 (de) * 1982-05-10 1990-03-15 Takeda Chemical Industries Ltd Dihydropyridinderivate, deren herstellung und verwendung.
US4603135A (en) * 1983-10-17 1986-07-29 Takeda Chemical Industries, Ltd. Substituted piperazinyl alkyl esters of 2-amino-4-aryl-1,4-dihydro-6-alkyl-3,5-pyridinedicarboxylates
US4678796A (en) * 1984-11-30 1987-07-07 Warner-Lambert Company 2-alkylidene derivatives of 1,2,3,4-tetrahydropyridine-2,5-pyridine carboxylic acid dialkyl esters useful for treatment of cardiovascular disorders
CA1267416A (en) 1985-06-17 1990-04-03 Ila Sircar 1,4-dihydropyridine derivatives useful for the treatment of cardiovascular disorders
US4732898A (en) * 1986-04-29 1988-03-22 Warner-Lambert Company 2-(2-aryl-2-oxoalkylidene) analogs of-3,5-pyridinedicarboxylic acid dialkyl esters useful for treatment of cardiovascular disorders
SE8701172D0 (sv) * 1987-03-20 1987-03-20 Sandvik Ab Whiskerforsterkt keramiskt skerverktyg
KR102621342B1 (ko) 2017-12-22 2024-01-08 도레이 카부시키가이샤 테이프형 프리프레그 및 그의 제조 방법

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3441648A (en) * 1967-02-07 1969-04-29 Smithkline Corp Compositions and methods for lowering blood pressure with 1,4-dihydropyridines
DE1670827C3 (de) * 1967-03-20 1974-10-24 Bayer Ag, 5090 Leverkusen 4-(2'-Nitrophenyl)-2,6-dimethyl-3,5-dicarbmethoxy-1,4-dihydropyridin
DE1670824C3 (de) * 1967-03-20 1978-08-03 Bayer Ag, 5090 Leverkusen 1,4-Dihydropyridin-33-dicarbonsäurealkylester
DE1923990C3 (de) * 1969-05-10 1978-11-23 Bayer Ag Verfahren zur Herstellung von N-substituierten M-Dihydropyridin-S.S-dicarbonsäureestern
DE2013431C3 (de) * 1970-03-20 1979-12-20 Bayer Ag, 5090 Leverkusen 4-Azidophenyl-l,4-dihydropyridin-3,5-dicarbonsäureester

Also Published As

Publication number Publication date
FR2195450B1 (ko) 1977-09-09
US3959292A (en) 1976-05-25
DE2239815A1 (de) 1974-02-21
NL7311031A (ko) 1974-02-14
PL89396B1 (ko) 1976-11-30
JPS5626660B2 (ko) 1981-06-19
HU167991B (ko) 1976-02-28
AT327194B (de) 1976-01-26
DK136062C (da) 1978-01-09
CA1016945A (en) 1977-09-06
DE2239815C2 (de) 1983-02-10
FI55998C (fi) 1979-11-12
LU68206A1 (ko) 1973-10-16
CH583196A5 (ko) 1976-12-31
NO139130B (no) 1978-10-02
CS178892B2 (en) 1977-10-31
FI55998B (fi) 1979-07-31
IE37989B1 (en) 1977-11-23
IL42933A0 (en) 1973-11-28
YU36172B (en) 1982-02-25
KR780000072B1 (en) 1978-03-30
AU469267B2 (en) 1976-02-05
RO62914A (fr) 1977-11-15
AU5912473A (en) 1975-02-13
IL42933A (en) 1977-04-29
DD109627A5 (ko) 1974-11-12
BG22816A3 (ko) 1977-04-20
ZA735460B (en) 1974-07-31
SU475772A3 (ru) 1975-06-30
ATA707073A (de) 1975-04-15
GB1384219A (en) 1975-02-19
ES417807A1 (es) 1976-03-01
DK136062B (da) 1977-08-08
JPS4945079A (ko) 1974-04-27
SE386164B (sv) 1976-08-02
BE803474A (fr) 1974-02-11
YU213373A (en) 1981-06-30
FR2195450A1 (ko) 1974-03-08
IE37989L (en) 1974-02-12

Similar Documents

Publication Publication Date Title
SE395366B (sv) Forfarande for framstellning av porosa tabletter
SE404019B (sv) Forfarande for framstellnig av n-fosfonometylglycin
SE400771B (sv) Forfarande for framstellning av 3alfa-hydroxi- och 3alfa-hydroxi-19-norpregnaner
SE413246B (sv) Forfarande for framstellning av kolesteroloxidas
SE415261B (sv) Forfarande for framstellning av berarbundna polypeptider
SE419339B (sv) Forfarande for framstellning av substituerade sulfonylacetamidocefalosporiner
SE397530B (sv) Forfarande for framstellning av 1-pyrazolylalkyl-4-arylpiperazinderivat
NO140828C (no) Fremgangsmaate for fremstilling av pullulan
NO139124C (no) Fremgangsmaate for fremstilling av estere
SE423092B (sv) Forfarande for framstellning av vissa 13-tiaprostaglandiner
SE7611202L (sv) Forfarande for framstellning av pyrazolodiazepinforeningar
FI55626C (fi) Anordning foer framstaellning av en behaollare
NO139130C (no) Fremgangsmaate til fremstilling av 2-alkylamino-dihydropyridiner
NO139861C (no) Fremgangsmaate til fremstilling av 1-hydroksy-2-pyridoner
SE415146B (sv) Forfarande for framstellning av forbettrad epoxideringskatalysator
SE387344B (sv) Forfarande for framstellning av pyrazin-4-oxidderivat
SE385581B (sv) Forfarande for framstellning av foretrade n-metylolkarbamidforeningar
IT999554B (it) Procedimento per preparare diacetossibutano
SE402454B (sv) Forfarande for framstellning av 2-alkoxi-5-alkylsulfonyl-toluen
NO139353C (no) Fremgangsmaate til fremstilling av lipase
NO140185C (no) Fremgangsmaate til fremstilling av indolderivater
FI53452C (fi) Foerfarande foer framstaellning av n-laegre-alkyl-1,4-dihydro-4-oxokinolin-3-karboxylsyror
IT1033071B (it) Procedimento per prepare tiazolsolfenammidi
NO138563C (no) Fremgangsmaate til fremstilling av alfa-6-deoksytetracykliner
NO141951C (no) Fremgangsmaate for oppslutning av loev-ved.